Volume 5, Issue 1 (Autumn 2012)                   Iranian Journal of Blood and Cancer 2012, 5(1): 25-28 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Anoun S, Lamchahab M, Qachouh M, Benchekroun S, Quessar A. A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient. Iranian Journal of Blood and Cancer 2012; 5 (1) :25-28
URL: http://ijbc.ir/article-1-397-en.html
Abstract:   (8541 Views)
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
Full-Text [PDF 406 kb]   (4208 Downloads)    
: Original Article | Subject: Methodology
Received: 2012/04/10 | Accepted: 2012/07/18 | Published: 2013/05/30

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb